PRECIGEN, INC. Investment Income, Nonoperating
PRECIGEN, INC. (PGEN) reported Investment Income, Nonoperating of $366.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNonoperating · last filed 2026-08-04
- PRECIGEN, INC. investment income, nonoperating for the quarter ending 2026-06-30 was $366.00K, a 47.41% decline year-over-year.
- PRECIGEN, INC. investment income, nonoperating for the quarter ending 2026-03-31 was $683.00K, a 25.60% decline year-over-year.
- PRECIGEN, INC. investment income, nonoperating for the quarter ending 2025-06-30 was $696.00K.
- PRECIGEN, INC. investment income, nonoperating for the quarter ending 2025-03-31 was $918.00K.
- PRECIGEN, INC. investment income, nonoperating for fiscal 2025 was $3.21M, a 126.73% increase from fiscal 2024.
- PRECIGEN, INC. investment income, nonoperating for fiscal 2024 was $1.42M, a 56.19% decline from fiscal 2023.
- PRECIGEN, INC. investment income, nonoperating for fiscal 2023 was $3.24M.
- PRECIGEN, INC. investment income, nonoperating for fiscal 2018 was $19.08M, a 2.06% decline from fiscal 2017.
| Period end | Investment Income, Nonoperating 3 month | Investment Income, Nonoperating 3 month as first filed | Investment Income, Nonoperating 6 month | Investment Income, Nonoperating 6 month as first filed | Investment Income, Nonoperating 9 month | Investment Income, Nonoperating 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $366.00K 10-Q · filed 2026-08-04 | $1.05M 10-Q · filed 2026-08-04 | ||||
| 2026-03-31 | $683.00K 10-Q · filed 2026-05-13 | |||||
| 2025-12-31 | $3.21M 10-K · filed 2026-03-25 | |||||
| 2025-06-30 | $696.00K 10-Q · filed 2026-08-04 | $1.61M 10-Q · filed 2026-08-04 | ||||
| 2025-03-31 | $918.00K 10-Q · filed 2026-05-13 | |||||
| 2024-12-31 | $1.42M 10-K · filed 2026-03-25 | |||||
| 2023-12-31 | $3.24M 10-K · filed 2026-03-25 | |||||
| 2019-09-30 | $885.00K 10-Q · filed 2019-11-12 | $1.92M derived: sum of 2 quarters · filed 2019-11-12 | $3.28M 10-Q · filed 2019-11-12 | $5.04M derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2019-06-30 | $1.03M 10-Q · filed 2019-08-09 | $2.40M 10-Q · filed 2019-08-09 | $4.16M derived: sum of 3 quarters · filed 2019-08-09 | $10.26M derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2019-03-31 | $1.36M 10-Q · filed 2019-05-09 | $3.13M derived: sum of 2 quarters · filed 2019-05-09 | $9.23M derived: sum of 3 quarters · filed 2019-11-12 | $14.98M derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $7.87M derived: sum of 2 quarters · filed 2019-11-12 | $13.61M derived: sum of 3 quarters · filed 2019-11-12 | $19.08M 10-K · filed 2019-03-01 | ||
| 2018-09-30 | $6.11M 10-Q · filed 2019-11-12 | $11.85M derived: sum of 2 quarters · filed 2019-11-12 | $17.32M 10-Q · filed 2019-11-12 | $22.37M derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | $5.75M 10-Q · filed 2019-08-09 | $11.22M 10-Q · filed 2019-08-09 | $16.26M derived: sum of 3 quarters · filed 2019-08-09 | $21.33M derived: sum of 4 quarters · filed 2019-08-09 | ||
| 2018-03-31 | $5.47M 10-Q · filed 2019-05-09 | $10.52M derived: sum of 2 quarters · filed 2019-05-09 | $15.59M derived: sum of 3 quarters · filed 2019-05-09 | $20.33M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2017-12-31 | $5.05M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $10.12M derived: sum of 2 quarters · filed 2019-03-01 | $14.86M derived: sum of 3 quarters · filed 2019-03-01 | $19.48M 10-K · filed 2019-03-01 | ||
| 2017-09-30 | $5.07M 10-Q · filed 2018-11-08 | $9.81M derived: sum of 2 quarters · filed 2018-11-08 | $14.44M 10-Q · filed 2018-11-08 | $18.81M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | $4.74M 10-Q · filed 2018-08-13 | $9.37M 10-Q · filed 2018-08-13 | $13.74M derived: sum of 3 quarters · filed 2019-03-01 | $18.23M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | $4.62M 10-Q/A · filed 2018-08-13 | $9.00M derived: sum of 2 quarters · filed 2019-03-01 | $13.49M derived: sum of 3 quarters · filed 2019-03-01 | $14.20M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2016-12-31 | $4.37M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $8.87M derived: sum of 2 quarters · filed 2019-03-01 | $9.58M derived: sum of 3 quarters · filed 2019-03-01 | $10.19M 10-K · filed 2019-03-01 | ||
| 2016-09-30 | $4.49M 10-Q · filed 2017-11-09 | $5.21M derived: sum of 2 quarters · filed 2017-11-09 | $5.82M 10-Q · filed 2017-11-09 | $6.49M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-06-30 | $713.00K 10-Q · filed 2017-08-09 | $1.32M 10-Q · filed 2017-08-09 | $2.00M derived: sum of 3 quarters · filed 2018-03-01 | $2.56M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-03-31 | $610.00K 10-Q · filed 2017-05-10 | $1.28M derived: sum of 2 quarters · filed 2018-03-01 | $1.85M derived: sum of 3 quarters · filed 2018-03-01 | $2.19M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2015-12-31 | $673.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $1.24M derived: sum of 2 quarters · filed 2018-03-01 | $1.58M derived: sum of 3 quarters · filed 2018-03-01 | $1.88M 10-K · filed 2018-03-01 | ||
| 2015-09-30 | $567.00K 10-Q · filed 2016-11-09 | $911.00K derived: sum of 2 quarters · filed 2016-11-09 | $1.21M 10-Q · filed 2016-11-09 | $1.67M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-06-30 | $344.00K 10-Q · filed 2016-08-09 | $644.00K 10-Q · filed 2016-08-09 | $1.10M derived: sum of 3 quarters · filed 2017-03-01 | $1.30M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-03-31 | $300.00K 10-Q · filed 2016-05-10 | $757.00K derived: sum of 2 quarters · filed 2017-03-01 | $959.00K derived: sum of 3 quarters · filed 2017-03-01 | $1.07M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2014-12-31 | $457.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $659.00K derived: sum of 2 quarters · filed 2017-03-01 | $769.00K derived: sum of 3 quarters · filed 2017-03-01 | $806.00K 10-K · filed 2017-03-01 | ||
| 2014-09-30 | $202.00K 10-Q · filed 2015-11-09 | $312.00K derived: sum of 2 quarters · filed 2015-11-09 | $349.00K 10-Q · filed 2015-11-09 | $508.00K derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-30 | $110.00K 10-Q · filed 2015-08-10 | $198.00K 10-Q · filed 2015-08-10 | $306.00K derived: sum of 3 quarters · filed 2016-02-29 | $344.00K derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-31 | $88.00K 10-Q · filed 2015-05-11 | $196.00K derived: sum of 2 quarters · filed 2016-02-29 | $234.00K derived: sum of 3 quarters · filed 2016-02-29 | $249.00K derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $108.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $146.00K derived: sum of 2 quarters · filed 2016-02-29 | $161.00K derived: sum of 3 quarters · filed 2016-02-29 | $166.00K 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $38.00K 10-Q · filed 2014-11-13 | $53.00K derived: sum of 2 quarters · filed 2014-08-14 | $58.00K 10-Q · filed 2014-11-13 | $60.00K derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-06-30 | $15.00K 10-Q · filed 2014-08-14 | $66.00K 10-Q/A · filed 2013-10-21 | $20.00K 10-Q · filed 2014-08-14 | $71.00K 10-Q/A · filed 2013-10-21 | $22.00K derived: sum of 3 quarters · filed 2015-03-02 | $23.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $5.00K 10-Q · filed 2014-05-09 | $7.00K derived: sum of 2 quarters · filed 2015-03-02 | $8.00K derived: sum of 3 quarters · filed 2015-03-02 | $9.00K derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2012-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $3.00K derived: sum of 2 quarters · filed 2015-03-02 | $4.00K derived: sum of 3 quarters · filed 2015-03-02 | $5.00K 10-K · filed 2015-03-02 | ||
| 2012-09-30 | $1.00K 10-Q · filed 2013-11-07 | $2.00K derived: sum of 2 quarters · filed 2013-11-07 | $3.00K 10-Q · filed 2013-11-07 | |||
| 2012-06-30 | $1.00K 10-Q/A · filed 2013-10-21 | $2.00K 10-Q/A · filed 2013-10-21 | ||||
| 2011-12-31 | $6.00K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |